About Yunfeng Capital
Yunfeng Capital is a private equity firm founded in 2010. It is primarily based in Shanghai, China. As of May 2026, Yunfeng Capital is an active investor with a portfolio of 158 companies, comprising 158 funding rounds and 5 acquisitions. In the last 12 months, it has participated in 7 funding rounds. The firm primarily invests in companies based in China and United States. Its portfolio is spread across a wide range of sectors from Consumer to Enterprise Applications. Its latest investment was a $***** Series B round in D-Robotics on Apr 08, 2026 which also saw participation from Prosperity7 Ventures, Envision Energy and other investors.
Overall Yunfeng Capital portfolio has seen 12 unicorns, 38 IPOs and 13 acquisitions including key companies like Kuaishou Technology, WuXi AppTec and Xiaomi. A lot of funds co-invest with Yunfeng Capital, with names like Alibaba Group sharing a substantial percentage of its portfolio.
Yunfeng Capital has a team of 35 people, including 10 partners.
Key Metrics
Founded Year
2010
Location
Shanghai, China
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
Yunfeng Capital's Portfolio
Yunfeng Capital has a portfolio of 158 companies. They have invested in a total of 158 companies. Their most recent investment was in D-Robotics (Series B round) on Apr 08, 2026. Here are the most recent investments by Yunfeng Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Apr 08, 2026 | Series B | 6742 | ||
Feb 24, 2026 | Series A | 2150 | ||
Feb 13, 2026 | Seed | 8772 | ||
Jan 23, 2026 | Series B | 5914 |
Yunfeng Capital has acquired 5 companies. Their most recent acquisition was of AMW on Jul 05, 2018. Here are the most recent acquisitions by Yunfeng Capital:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jul 05, 2018 | Transdermal drug delivery technologies | $6.36M | 2008 | |
Mar 12, 2018 | Offers products covering physical checkups, primary care service & medical management | $100M | 2004 | |
Dec 08, 2017 | Provider of biomedical diagnostic equipment manufacturer | - | 1980 | |
Jul 30, 2016 | Video Game developer specializing in casual games for mobile and web platforms | $1.5M | 2010 |
Here is the portfolio snapshot of Yunfeng Capital:
Investments by Year
The maximum number of investments were made in 2021
Acquisitions by Year
The maximum number of acquisitions were made in 2018
Portfolio by Location
Companies are primarily in China and United States
Portfolio by Sector
Companies are primarily in Consumer
Team profile of Yunfeng Capital
Yunfeng Capital has a team of 35 members including 10 Partners and 4 Principals located in China, Japan and 1 more location. Yunfeng Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Yunfeng Capital:
Co-investors of Yunfeng Capital
Over the past 16 years, 196 investors have co-invested in Yunfeng Capital's portfolio companies.
- Top Co-investors of Yunfeng Capital: 196 investors entered a company along with Yunfeng Capital. These include investors like Alibaba Group (10 companies).
Yunfeng Capital News
•
Shanji Technology completed tens of millions of yuan in Series Atidesight.com•Nov 24, 2024•Shargetech, IntelliFusion, Yunfeng Capital
•
China Digital Healthtech Taimei Technology Receives Approval For Hong Kong Ipo, Raised $413 Million With Investors Including Tencent, Yunfeng Capital, Softbank Group & Hillhouse Capital, Taimei Technology Was Founded In 2013 By Ceo Lu Zhao, Lu Zhao & Wife With 33.3% ShareholdingsCaproasia•Sep 19, 2024•Taimei Technology, Tencent, Yunfeng Capital, SoftBank Group and 1 other
•
•
China's Coherent Biopharma raises $100mAsian Venture Capital Journal•May 15, 2023•Coherent Biopharma, HM Capital, Yunfeng Capital, VCapital and 3 others
•
Etana Has Secured Financing From Deg, East Ventures And Other Global InvestorsPR Newswire•Mar 20, 2023•etanabiotech.com, DEG, Yunfeng Capital, East Ventures and 1 other
•
Etana secures financing from Jack Ma’s PE; InnovestX launches investment appShareandstocks•Oct 07, 2022•HLC, etanabiotech.com, Yunfeng Capital
•
Indonesia-based biopharma startup Etana secures series B fundingBioSpectrum Asia•Sep 28, 2022•etanabiotech.com, Yunfeng Capital, HLC
•
•
•
Sironax Closes $200M Series B FinancingFinSMEs•Aug 02, 2022•Sironax, Gaorong Capital, Yunfeng Capital, Temasek and 12 others
